These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 15015577)

  • 1. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells.
    Wang H; Zhao Y; Zeng L; Tang M; El-Deeb A; Li JJ; Cao Y
    Anticancer Res; 2004; 24(1):67-74. PubMed ID: 15015577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
    Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC
    J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB inhibitors induce lytic cytotoxicity in Epstein-Barr virus-positive nasopharyngeal carcinoma cells.
    Liu SF; Wang H; Lin XC; Xiang H; Deng XY; Li W; Tang M; Cao Y
    Cell Biol Int; 2008 Aug; 32(8):1006-13. PubMed ID: 18579417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
    Church TM; Verma D; Thompson J; Swaminathan S
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
    Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC
    Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
    Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
    J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-targeted gene therapy for nasopharyngeal carcinoma.
    Li JH; Chia M; Shi W; Ngo D; Strathdee CA; Huang D; Klamut H; Liu FF
    Cancer Res; 2002 Jan; 62(1):171-8. PubMed ID: 11782375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
    Chiang AK; Tao Q; Srivastava G; Ho FC
    Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus.
    Gutiérrez MI; Ibrahim MM; Dale JK; Greiner TC; Straus SE; Bhatia K
    J Natl Cancer Inst; 2002 Dec; 94(23):1757-63. PubMed ID: 12464647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
    Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
    J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
    Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS
    Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
    Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
    Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent and lytic Epstein-Barr virus replication strategies.
    Tsurumi T; Fujita M; Kudoh A
    Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.
    Horenstein MG; Nador RG; Chadburn A; Hyjek EM; Inghirami G; Knowles DM; Cesarman E
    Blood; 1997 Aug; 90(3):1186-91. PubMed ID: 9242551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.
    Zhang Q; Hong Y; Dorsky D; Holley-Guthrie E; Zalani S; Elshiekh NA; Kiehl A; Le T; Kenney S
    J Virol; 1996 Aug; 70(8):5131-42. PubMed ID: 8764021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1.
    Prang N; Wolf H; Schwarzmann F
    J Virol; 1995 Apr; 69(4):2644-8. PubMed ID: 7884918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
    Deakyne JS; Malecka KA; Messick TE; Lieberman PM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
    Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
    Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceramide promotes lytic reactivation of Epstein-Barr virus in gastric carcinoma.
    Kim JY; Min YJ; Lee M-H; An YR; Ashktorab H; Smoot DT; Kwon SW; Lee SK
    J Virol; 2024 Feb; 98(2):e0177623. PubMed ID: 38197630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.